Tenae Griffin
Internal Medicine · Kings Mountain, NCNPI 1245709070
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,039 and has fallen 74.5% since, to $265 in 2025.
Across 63 payments — averaging $45.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$553
- AstraZeneca$322
- GSK$258
- Alkermes, Inc.$225
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$222
- Medtronic$169
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,871100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $553 |
| AstraZeneca | 11 | $322 |
| GSK | 5 | $258 |
| Alkermes, Inc. | 2 | $225 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $222 |
| Medtronic | 1 | $169 |
| Grifols USA, LLC | 1 | $145 |
| Argenx US, Inc. | 2 | $134 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Ironshore Pharmaceuticals Inc. | 2 | $110 |
| Exact Sciences | 1 | $88 |
| Alnylam Pharmaceuticals Inc. | 1 | $87 |
| Johnson & Johnson | 1 | $77 |
| Novo Nordisk | 4 | $75 |
| Xeris Pharmaceuticals, Inc. | 2 | $74 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Pfizer | 2 | $37 |
| Lilly USA, LLC | 1 | $25 |
| Novartis | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$899
- UBRELVY$240
- CAPLYTA$222
- MINIMED 780G$169
- Prolastin-C Liquid$145
- FARXIGA$135
- VRAYLAR$125
- QULIPTA$123
- ABILIFY MAINTENA$120
How this compares
$2,871 in reported general payments places this provider in the 85th percentile of 3,302 internal medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 25 | $548 |
| Amlodipine Besylate | 54 | $499 |
| Atorvastatin Calcium | 42 | $397 |
| Famotidine | 14 | $327 |
| Gabapentin | 24 | $249 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $158 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $119 |
| Trazodone Hcl | 27 | $107 |
| Lisinopril | 23 | $90 |
| Losartan Potassium | 11 | $88 |
| Metformin Hcl | 17 | $87 |
| Hydrochlorothiazide | 23 | $78 |
| Metoprolol Tartrate | 20 | $44 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Kings Mountain
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
- Jamy ArdWinston Salem$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.